drugset / Trial / NCT01193855
Dutasteride in Treating Patients With Prostate Cancer
RandomizedDouble-blindTreatment
Summary
RATIONALE: Dutasteride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This randomized phase II trial is studying how well giving dutasteride works in treating patients with prostate cancer.
Timeline
- Start
- 2010-06
- Primary completion
- 2012-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dutasteride | Small molecule | 0.5 mg | Oral |